QUOTIENT LTD. Daily Stock Analysis

Daily Stock Analysis, QTRX, QUOTIENT LTD, priceseries

QUOTIENT LTD. Daily Stock Analysis
Stock Information
Open
29.65
Close
27.66
High
30.06
Low
27.23
Previous Close
29.71
Daily Price Gain
-2.05
YTD High
43.32
YTD High Date
Jan 3, 2022
YTD Low
25.32
YTD Low Date
Jan 24, 2022
YTD Price Change
-14.75
YTD Gain
-34.78%
52 Week High
69.22
52 Week High Date
Jun 14, 2021
52 Week Low
25.32
52 Week Low Date
Jan 24, 2022
52 Week Price Change
-31.14
52 Week Gain
-52.96%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Sep 14. 2018
16.43
Oct 2. 2018
20.27
12 Trading Days
23.38%
Link
LONG
Nov 27. 2018
17.19
Dec 14. 2018
19.06
12 Trading Days
10.87%
Link
LONG
Jan 7. 2019
19.02
Jan 15. 2019
20.13
6 Trading Days
5.86%
Link
LONG
Feb 6. 2019
20.99
Mar 6. 2019
23.70
19 Trading Days
12.92%
Link
LONG
May 30. 2019
23.40
Jun 25. 2019
33.32
18 Trading Days
42.40%
Link
LONG
Nov 19. 2019
23.17
Dec 4. 2019
24.74
10 Trading Days
6.79%
Link
LONG
Jan 21. 2020
25.14
Feb 12. 2020
26.87
16 Trading Days
6.88%
Link
LONG
Mar 26. 2020
16.27
May 1. 2020
25.10
25 Trading Days
54.30%
Link
LONG
Aug 11. 2020
33.42
Aug 24. 2020
35.37
9 Trading Days
5.83%
Link
LONG
Oct 5. 2020
35.35
Oct 20. 2020
40.97
11 Trading Days
15.91%
Link
LONG
Nov 3. 2020
39.30
Nov 18. 2020
46.53
11 Trading Days
18.41%
Link
LONG
Jan 12. 2021
59.59
Jan 26. 2021
69.69
9 Trading Days
16.94%
Link
LONG
Feb 1. 2021
69.45
Feb 22. 2021
83.46
14 Trading Days
20.17%
Link
LONG
Mar 31. 2021
58.47
Apr 12. 2021
62.55
7 Trading Days
6.98%
Link
LONG
Jun 2. 2021
51.04
Jun 22. 2021
61.02
14 Trading Days
19.55%
Link
LONG
Oct 28. 2021
50.17
Nov 10. 2021
53.04
9 Trading Days
5.73%
Link
Company Information
Stock Symbol
QTRX
Exchange
NASDAQ
Company URL
http://www.quotientbd.com
Company Phone
41274832286
CEO
Paul Cowan
Headquarters
-
Business Address
28 ESPLANADE, SAINT HELIER, JERSEY JE2 3QA
Sector
Equity
Industry Category
Drugs
Industry Group
Diagnostic Substances
CIK
0001596946
About

Quotient Ltd. operates as a diagnostics company. It provides immunohematology products to hospitals and blood banks. The company develops, manufactures and sells conventional reagent products to equipment manufacturers. It engages in transfusion diagnostics, which focuses on blood grouping and serological disease screening. Quotient was founded on January 28, 2012 and is headquartered in Penicuik, the United Kingdom.

Description

Quotient Limited, a diagnostics company, develops, manufactures, and commercializes blood transfusion diagnostic products worldwide. The company is developing MosaiQ, a proprietary technology platform, which provides tests for blood grouping and serological disease screening. It also develops, manufactures, and commercializes conventional reagent products for blood grouping, including antisera products that are used to identify blood-group antigens; reagent red blood cells, which enable the identification of blood-group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company sells its products to donor collection agencies, hospitals, independent testing laboratories, blood banking operations, and other diagnostic companies, as well as to original equipment manufacturers. Quotient Limited was founded in 2007 and is based in Penicuik, the United Kingdom.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading